Home Health Conditions Statins and Cholesterol – Cure or Not

Statins and Cholesterol – Cure or Not

It is undeniably true that statins such as Crestor and Lipitor lower cholesterol levels in the human body.

The question is, is that a good thing?

Doctors have told the general public that high cholesterol levels are deadly ever since researchers first discovered statins in the blood.  They have insisted that we all need to lower our cholesterol levels.


Drug companies developed statin drugs in the 1970s.  These drugs have gradually increased in popularity through the years.   Today, statistics indicate that one in four adults over the age of 45 is taking a statin drug.

One would think, however, that if statin drugs were so incredibly effective, the incidence of heart disease should have dropped dramatically since the advent of statins.

Unfortunately for big pharma, statistics show that this is not the case.

Instead, more recent research is beginning to indicate that statins may cause serious side effects.  These side effects include increased levels of diabetes, liver injury, memory loss, and muscle damage.  Heart disease has not decreased at all, however.

Statins Patent

The patent on Lipitor expired in 2011.  Since then, America’s Food and Drug Administration has issued warnings against statin drugs.  

The FDA has issued statements saying that there is a link between statin use and increased levels of diabetes, liver injury, memory loss (and possibly Alzheimer’s disease) and muscle damage.

In recent years, thousands of people have filed lawsuits against the drug companies that produce statins.  This is not widely publicized.

It is becoming nearly impossible to trust scientific research.  It is increasingly obvious that huge percentages of new research is sponsored by those who stand to gain from manipulating the results.

For this reason, it is important to know who paid for any scientific study. Never allow a study to convince you to change your lifestyle unless you know what influenced the research.

Perhaps the current push for Investor State Dispute Settlement clauses in all global trade agreements is partly the result of the public’s unwillingness to let themselves be harmed without protest.